2024

• Cozzi, M., Invernizzi, A., Monteduro, D., Esposito, R., Spooner, K., Fraser-Bell, S., Staurenghi, G., Romano, F., Airaldi, M., Chang, A. (2024). Lesion area progression in eyes with neovascular age-related macular degeneration treated using a proactive or a reactive regimen. Eye, 38(1), 161-167. [More Information]

2023

• Cornish, E., Wickremasinghe, S., Mehta, H., Lim, L., Sandhu, S., Nguyen, V., Gillies, M., Fraser-Bell, S. (2023). Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO). Eye. [More Information]
• Mitchell, P., Arnold, J., Fraser-Bell, S., Kang, H., Chang, A., Tainton, J., Simonyi, S. (2023). Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: The AUSSIEDEX study. BMJ Open Ophthalmology, 8(1). [More Information]
• Fraser-Bell, S., Kang, H., Mitchell, P., Arnold, J., Tainton, J., Simonyi, S. (2023). Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX study. British Journal of Ophthalmology, 107(1), 72-78. [More Information]
• Yuen, Y., Gilhotra, J., Dalton, M., Aujla, J., Mehta, H., Wickremasinghe, S., Uppal, G., Arnold, J., Chen, F., Chang, A., Fraser-Bell, S., Bowditch, E., Broadhead, G., et al (2023). Diabetic Macular Oedema Guidelines: An Australian Perspective. Journal of Ophthalmology, 2023. [More Information]
• Cornish, E., Zagora, S., Spooner, K., Fraser-Bell, S. (2023). Management of macular oedema due to retinal vein occlusion: An evidence-based systematic review and meta-analysis. Clinical and Experimental Ophthalmology. [More Information]
• Shah, J., Nguyen, V., Hunt, A., Mehta, H., Romero-Nunez, B., Zarranz-Ventura, J., Viola, F., Bougamha, W., Barnes, R., Barthelmes, D., Gillies, M., Fraser-Bell, S. (2023). Re: Shah et al.: Characterization of Poor Visual Outcomes of Diabetic Macular Edema: The Fight Retinal Blindness! Project (Ophthalmol Retina. 2022;6:540-547.). Ophthalmology Retina, 7(3), e5-e6. [More Information]
• Chaudhary, V., Sarohia, G., Phillips, M., Park, D., Xie, J., Zeraatkar, D., Fung, M., Thabane, L., Loewenstein, A., Holz, F., Fraser-Bell, S., et al (2023). Role of anti-vascular endothelial growth factor in the management of non-proliferative diabetic retinopathy without centre-involving diabetic macular oedema: a meta-analysis of trials. Eye, 37(10), 1966-1974. [More Information]
• Romano, F., Lamanna, F., Gabrielle, P., Teo, K., Battaglia Parodi, M., Iacono, P., Fraser-Bell, S., Cornish, E., Nassisi, M., Viola, F., Invernizzi, A., et al (2023). Update on Retinal Vein Occlusion. Asia-Pacific Journal of Ophthalmology, 12(2), 196-210. [More Information]
• Iglicki, M., Busch, C., Lanzetta, P., Sarao, V., Veritti, D., Rassu, N., Lupidi, M., Cebeci, Z., Fraser-Bell, S. (2023). Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO—Is there any difference? the VITDEX study. Eye, 37(2), 280-284. [More Information]

2022

• Niedzwiecki, M., Hunt, A., Nguyen, V., Mehta, H., Creuzot-Garcher, C., Gabrielle, P., Guillemin, M., Fraser-Bell, S., Arnold, J., McAllister, I., Gillies, M., Barthelmes, D. (2022). 12-month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry. Acta Ophthalmologica, 100(4), e920-e927. [More Information]
• Shah, J., Nguyen, V., Hunt, A., Mehta, H., Romero-Nuñez, B., Zarranz-Ventura, J., Viola, F., Bougamha, W., Barnes, R., Barthelmes, D., Gillies, M., Fraser-Bell, S. (2022). Characterization of Poor Visual Outcomes of Diabetic Macular Edema: The Fight Retinal Blindness! Project. Ophthalmology Retina, 6(7), 540-547. [More Information]
• Gabrielle, P., Nguyen, V., Bhandari, S., Mehta, H., Viola, F., Arnold, J., Fraser-Bell, S., Barthelmes, D., Creuzot-Garcher, C., Gillies, M. (2022). Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry. Acta Ophthalmologica, 100(3), 285-294. [More Information]
• Spooner, K., Fraser-Bell, S., Hong, T., Wong, J., Chang, A. (2022). Long-term outcomes of anti-VEGF treatment of retinal vein occlusion. Eye, 36(6), 1194-1201. [More Information]
• Wang, N., Hunt, A., Nguyen, V., Shah, J., Fraser-Bell, S., McAllister, I., Barthelmes, D., Gillies, M., Squirrell, D. (2022). One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion. Clinical and Experimental Ophthalmology, 50(9), 1038-1046. [More Information]
• Chaikitmongkol, V., Ozimek, M., Srisomboon, T., Patikulsila, D., Cebeci, Z., Chhablani, J., Choovuthayakorn, J., Watanachai, N., Kunavisarut, P., Rodríguez-Valdes, P., Fung, A., Mehta, H., Fraser-Bell, S., Invernizzi, A., et al (2022). Polypoidal Choroidal Vasculopathy Based on Non-ICGA Criteria In White Patients With Neovascular Age-Related Macular Degeneration. American Journal of Ophthalmology, 244, 58-67. [More Information]
• Bartimote, C., Dunn, H., Fraser-Bell, S. (2022). Reactivation of Multifocal Choroiditis Associated with Treatment in Latent Tuberculosis. Case Reports in Ophthalmology, 13(3), 855-861. [More Information]
• Mack, H., Colville, D., Harraka, P., Savige, J., Invernizzi, A., Fraser-Bell, S. (2022). Retinal findings in glomerulonephritis. Clinical and Experimental Optometry, 105(5), 474-486. [More Information]
• Hunt, A., Nguyen, V., Creuzot-Garcher, C., Alforja, S., Gabrielle, P., Zarranz-Ventura, J., Guillemin, M., Fraser-Bell, S., Casaroli-Marano, R., Arnold, J., Gillies, M., et al (2022). Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry. British Journal of Ophthalmology, 106(8), 1178-1184. [More Information]

2021

• Mack, H., Fraser-Bell, S. (2021). "COVID new normal" in ophthalmology: Implications for ophthalmologists, eye care, ophthalmic education and research. Clinical and Experimental Ophthalmology, 49(1), 9-11. [More Information]
• Paez-Escamilla, M., Jhingan, M., Gallagher, D., Singh, S., Fraser-Bell, S., Chhablani, J. (2021). Age-related macular degeneration masqueraders: From the obvious to the obscure. Survey of Ophthalmology, 66(2), 153-182. [More Information]
• Bartimote, C., Fraser-Bell, S., Dunn, H. (2021). Asymptomatic occlusive retinal vasculitis in newly diagnosed active tuberculosis. Respiratory Medicine Case Reports, 33, 101456. [More Information]
• Mack, H., Hassall, M., Hall, A., Simunovic, M., Fraser-Bell, S., Ayton, L. (2021). Cystoid Macular Edema. In Not known (Eds.), Comprehensive Pharmacology, (pp. 1-37). TBC. [More Information]
• Salem, W., Zagora, S., Nguyen, V., Mehta, H., Gillies, M., Fraser-Bell, S. (2021). Effect of intravitreal injection speed on acute rise in intraocular pressure. The SPEED IOP study. Clinical and Experimental Ophthalmology, 49(5), 519-521. [More Information]
• Cornish, E., Teo, K., Gillies, M., Lim, L., Nguyen, V., Wickremasinghe, S., Mehta, H., McAllister, I., Fraser-Bell, S. (2021). Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema. British Journal of Ophthalmology, 107(1), 79 - 83-83. [More Information]
• Rodríguez-Valdés, P., Rehak, M., Zur, D., Sala-Puigdollers, A., Fraser-Bell, S., Lupidi, M., Chhablani, J., Cebeci, Z., Laíns, I., Chaikitmongkol, V., Fung, A., et al (2021). GRAding of functional and anatomical response to DExamethasone implant in patients with Diabetic Macular Edema: GRADE-DME Study. Scientific Reports, 11(1), 4738. [More Information]
• Spooner, K., Fraser-Bell, S., Hong, T., Phan, L., Wong, J., Chang, A. (2021). Long-term Anti–Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: The LATAR Study: Report 1: Ten-Year, Real-World Outcomes. Ophthalmology Retina, 5(6), 511-518. [More Information]
• Cornish, E., Nguyen, V., Young, S., Fraser-Bell, S., Guymer, R., Squirrell, D., Barthelmes, D., Gillies, M. (2021). Neovascular age-related macular degeneration at treatment intervals of 14 or greater. Clinical and Experimental Ophthalmology, 49(6), 570-578. [More Information]
• Singh, S., Fraser-Bell, S., Dogra, A., Sahoo, N., Gabrielle, P., Lupidi, M., Al-Sheikh, M., Borrelli, E., Sacconi, R., Querques, G., et al (2021). Optical coherence tomography angiography findings of fellow eye of proliferative macular telangiectasia type 2: Long term study. European Journal of Ophthalmology, 31(4), 1933-1939. [More Information]
• Spooner, K., Fraser-Bell, S., Hong, T., Chang, A. (2021). Optical-coherence tomography angiography and ultrawide-field angiography findings in eyes with refractory macular edema secondary to retinal vein occlusion switched to aflibercept: A subanalysis from a 48-week prospective study. Taiwan Journal of Ophthalmology, 11(4), 352-358. [More Information]
• Spooner, K., Fraser-Bell, S., Hong, T., Chang, A. (2021). Patient-reported outcomes from a phase IV study of aflibercept in patients with refractory retinal vein occlusions. Taiwan Journal of Ophthalmology, 11(3), 244-250. [More Information]
• Bhandari, S., Nguyen, V., Fraser-Bell, S., Di Tanna, G., Gillies, M. (2021). Real-world prognosis of eyes with diabetic macular oedema receiving treatment with vascular endothelial growth factor (VEGF) inhibitors. Cochrane Database of Systematic Reviews, 2021 (10), CD015030-1-CD015030-15. [More Information]
• Fung, A., Guan, R., Forlani, V., Li, Y., Chhablani, J., Maltsev, D., Zur, D., Iglicki, M., Couturier, A., Shinojima, A., Gabrielle, P., Fraser-Bell, S., Chen, Y., et al (2021). Subclinical subretinal fluid detectable only by optical coherence tomography in choroidal naevi-the SON study. Eye, 35(7), 2038-2044. [More Information]
• Kam, A., Collins, S., Park, T., Mihail, M., Stanaway, F., Lewis, N., Polya, D., Fraser-Bell, S., Roberts, T., Smith, J. (2021). Using Lean Six Sigma techniques to improve efficiency in outpatient ophthalmology clinics. BMC Health Services Research, 21(1), 38. [More Information]

2020

• Busch, C., Okada, M., Zur, D., Fraser-Bell, S., Rodríguez-Valdés, P., Cebeci, Z., Lupidi, M., Fung, A., Gabrielle, P., Giancipoli, E., et al (2020). Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity. Acta Ophthalmologica, 98(7), e801-e806. [More Information]
• Biechl, A., Bhandari, S., Nguyen, V., Arnold, J., Young, S., Fraser-Bell, S., Mehta, H., Gillies, M., Barthelmes, D. (2020). Changes in real-world treatment patterns for diabetic macular oedema from 2009 to 2019 and 5-year outcomes: Data from the Fight Retinal Blindness! Registry. Clinical and Experimental Ophthalmology, 48(6), 802-812. [More Information]
• Zur, D., Iglicki, M., Sala-Puigdollers, A., Chhablani, J., Lupidi, M., Fraser-Bell, S., Mendes, T., Chaikitmongkol, V., Cebeci, Z., Dollberg, D., Invernizzi, A., et al (2020). Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant. Acta Ophthalmologica, 98(2), e217-e223. [More Information]
• Spooner, K., Fraser-Bell, S., Hong, T., Chang, A. (2020). Effects of Switching to Aflibercept in Treatment Resistant Macular Edema Secondary to Retinal Vein Occlusion. Asia-Pacific Journal of Ophthalmology, 9(1), 48-53. [More Information]
• Shah, J., Vaze, A., Tang Lee Say, T., Gillies, M., Fraser-Bell, S. (2020). Emerging corticosteroid delivery platforms for treatment of diabetic macular edema. Expert Opinion on Emerging Drugs, 25(4), 383-394. [More Information]
• Zagora, S., Fraser-Bell, S. (2020). Emerging therapies for common eye conditions. Clinical and Experimental Ophthalmology, 48(8), 1029-1030. [More Information]
• Spooner, K., Fraser-Bell, S., Cozzi, M., Staurenghi, G., Invernizzi, A., Monteduro, D., Munk, M., Hong, T., Chang, A. (2020). Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of the MANEX Study. Ophthalmology, 127(12), 1663-1673. [More Information]
• Govindahari, V., Fraser-Bell, S., Ayachit, A., Invernizzi, A., Nair, U., Nair, D., Lupidi, M., Singh, S., Rajendran, A., Zur, D., et al (2020). Multicolor imaging in macular telangiectasia—a comparison with fundus autofluorescence. Graefe's Archive for Clinical and Experimental Ophthalmology, 258(11), 2379-2387. [More Information]
• Singh, S., Fung, A., Fraser-Bell, S., Lupidi, M., Mohan, S., Gabrielle, P., Zur, D., Iglicki, M., López-Corell, P., Gallego-Pinazo, R., et al (2020). One year outcomes of anti vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation. The British Journal of Ophthalmology, 104(5), 678-683. [More Information]
• Shen, W., Teo, K., Wood, J., Vaze, A., Chidlow, G., Ao, J., Lee, S., Yam, M., Cornish, E., Fraser-Bell, S., Gillies, M., et al (2020). Preclinical and clinical studies of photobiomodulation therapy for macular oedema. Diabetologia, 63(9), 1900-1915. [More Information]
• Spooner, K., Fraser-Bell, S., Hong, T., Chang, A. (2020). Prospective study of aflibercept for the treatment of persistent macular oedema secondary to retinal vein occlusions in eyes not responsive to long-term treatment with bevacizumab or ranibizumab. Clinical and Experimental Ophthalmology, 48(1), 53-60. [More Information]
• Bhandari, S., Nguyen, V., Fraser-Bell, S., Mehta, H., Viola, F., Baudin, F., Gabrielle, P., Creuzot-Garcher, C., Gillies, M., Barthelmes, D. (2020). Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry. Ophthalmology, 127(5), 608-615. [More Information]
• Fraser-Bell, S., Gillies, M. (2020). The impact of the Lucentis, Eylea, Avastin in Vein Occlusion (LEAVO) Study in Australia. Eye, 34(2), 223-224. [More Information]

2019

• Busch, C., Iglicki, M., Okada, M., Gabrielle, P., Cohen, S., Mariussi, M., Amphornphruet, A., Cebeci, Z., Chaikitmongkol, V., Couturier, A., Fraser-Bell, S., Fung, A., et al (2019). Causative Pathogens of Endophthalmitis after Intravitreal Anti-VEGF Injection: An International Multicenter Study. Ophthalmologica, 241(4), 211-219. [More Information]
• Spooner, K., Hong, T., Fraser-Bell, S., Chang, A. (2019). Current Outcomes of Anti-VEGF Therapy in the Treatment of Macular Edema Secondary to Central Retinal Vein Occlusions: A Systematic Review and Meta-Analysis. Asia-Pacific Journal of Ophthalmology, 8(3), 236-246. [More Information]
• Spooner, K., Hong, T., Fraser-Bell, S., Chang, A. (2019). Current Outcomes of Anti-VEGF Therapy in the Treatment of Macular Oedema Secondary to Branch Retinal Vein Occlusions: A Meta-Analysis. Ophthalmologica, 242(3), 163-177. [More Information]
• Mehta, H., Lim, L., Nguyen, V., Qatarneh, D., Wickremasinghe, S., Hodgson, L., Quin, G., McAllister, I., Gillies, M., Fraser-Bell, S. (2019). Development of New Proliferative Diabetic Retinopathy in the BEVORDEX Trial. Ophthalmology Retina, 3(3), 286-287. [More Information]
• Iglicki, M., Busch, C., Zur, D., Okada, M., Mariussi, M., Chhablani, J., Cebeci, Z., Fraser-Bell, S., Chaikitmongkol, V., Couturier, A., Fung, A., et al (2019). DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study. Retina, 39(1), 44-51. [More Information]
• Joe, A., Wickremasinghe, S., Gillies, M., Nguyen, V., Lim, L., Mehta, H., Fraser-Bell, S. (2019). Dexamethasone implant for the treatment of persistent diabetic macular oedema despite long-term treatment with bevacizumab. Clinical and Experimental Ophthalmology, 47(2), 287-289. [More Information]
• Spooner, K., Fraser-Bell, S., Hong, T., Chang, A. (2019). Five-year outcomes of retinal vein occlusion treated with vascular endothelial growth factor inhibitors. BMJ Open Ophthalmology, 4(1), 1-10. [More Information]
• Nguyen, V., Vaze, A., Fraser-Bell, S., Arnold, J., Essex, R., Barthelmes, D., Gillies, M. (2019). Outcomes of Suspending VEGF Inhibitors for Neovascular Age-Related Macular Degeneration When Lesions Have Been Inactive for 3 Months. Ophthalmology Retina, 3(8), 623-628. [More Information]
• Nguyen, V., Daien, V., Guymer, R., Young, S., Hunyor, A., Fraser-Bell, S., Hunt, A., Gillies, M., Barthelmes, D. (2019). Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular Degeneration. Ophthalmology, 126(1), 64-74. [More Information]
• Busch, C., Fraser-Bell, S., Iglicki, M., Lupidi, M., Couturier, A., Chaikitmongkol, V., Giancipoli, E., Rodríguez-Valdés, P., Gabrielle, P., Laíns, I., et al (2019). Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results. Acta Diabetologica, 56(12), 1341-1350. [More Information]
• Busch, C., Fraser-Bell, S., Zur, D., Rodriguez-Valdes, P., Cebeci, Z., Lupidi, M., Fung, A., Gabrielle, P., Giancipoli, E., Chaikitmongkol, V., et al (2019). Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study. Acta Diabetologica, 56(7), 777-784. [More Information]

2018

• Leung, V., Weaver, T., Fraser-Bell, S., Roberts, T. (2018). Acute retinopathy and loss of vision following routine cataract surgery. Clinical and Experimental Ophthalmology, 47(2), 294-296. [More Information]
• Mehta, H., Hennings, C., Gillies, M., Nguyen, V., Campain, A., Fraser-Bell, S. (2018). Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema. Cochrane Database of Systematic Reviews, 2018 (4), 1-70. [More Information]
• Hui, M., Raniga, A., Fraser-Bell, S., Salem, W., Clement, C. (2018). Comparison of ICare tonometry to Goldmann tonometry for the measurement of intraocular pressure changes following intravitreal anti-vascular endothelial growth factor injection. Clinical and Experimental Ophthalmology, 46(7), 821-823. [More Information]
• Busch, C., Zur, D., Fraser-Bell, S., Lains, I., Santos, A., Lupidi, M., Cagini, C., Gabrielle, P., Couturier, A., Mane-Tauty, V., et al (2018). Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema. Acta Diabetologica, 55(8), 789-796. [More Information]
• Mehta, H., Fraser-Bell, S., Nguyen, V., Lim, L., Gillies, M. (2018). Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years: results from the BEVORDEX randomised clinical trial of bevacizumab versus dexamethasone implants for diabetic macular oedema. British Journal of Ophthalmology, 102(4), 479-482. [More Information]
• Mehta, H., Fraser-Bell, S., Nguyen, V., Lim, L., Gillies, M. (2018). The Interval between Treatments of Bevacizumab and Dexamethasone Implants for Diabetic Macular Edema Increased over Time in the BEVORDEX Trial. Ophthalmology Retina, 2(3), 231-234. [More Information]
• Teo, K., Gillies, M., Fraser-Bell, S. (2018). The use of vascular endothelial growth factor inhibitors and complementary treatment options in polypoidal choroidal vasculopathy: A subtype of neovascular age-related macular degeneration. International Journal of Molecular Sciences, 19(9), 1-14. [More Information]

2017

• Fraser-Bell, S., Symes, R., Vaze, A. (2017). Hypertensive eye disease: a review. Clinical and Experimental Ophthalmology, 45(1), 45-53. [More Information]
• Wickremasinghe, S., Fraser-Bell, S., Alessandrello, E., Mehta, H., Gillies, M., Lim, L. (2017). Retinal vascular calibre changes after intravitreal bevacizumab or dexamethasone implant treatment for diabetic macular oedema. British Journal of Ophthalmology, 101(10), 1329-1333. [More Information]

2016

• Fraser-Bell, S., Lim, L., Campain, A., Mehta, H., Aroney, C., Bryant, J., Li, J., Quin, G., McAllister, I., Gillies, M. (2016). Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study). Ophthalmology, 123(6), 1399-1401. [More Information]
• Mehta, H., Gillies, M., Fraser-Bell, S. (2016). Combination of vascular endothelial growth factor inhibitors and laser therapy for diabetic macular oedema: a review. Clinical and Experimental Ophthalmology, 44(4), 335-339. [More Information]
• Mehta, H., Fraser-Bell, S., Yeung, A., Campain, A., Lim, L., Quin, G., McAllister, I., Keane, P., Gillies, M. (2016). Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: Data from the BEVORDEX randomised clinical trial. British Journal of Ophthalmology, 100(7), 1000-1004. [More Information]
• Vaze, A., Symes, R., Fraser-Bell, S. (2016). Management of diabetic retinopathy: An update. Medicine Today, 17(8), 63-65.
• Aroney, C., Fraser-Bell, S., Lamoureux, E., Gillies, M., Lim, L., Fenwick, E. (2016). Vision-related quality of life outcomes in the BEVORDEX study: A clinical trial comparing ozurdex sustained release dexamethasone intravitreal implant and bevacizumab treatment for diabetic macular edema. Investigative Ophthalmology and Visual Science, 57(13), 5541-5546. [More Information]

2015

• Mehta, H., Fraser-Bell, S., Campain, A., Gillies, M. (2015). Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2015 (3). [More Information]
• Wong, E., Fraser-Bell, S., Hunyor, A., Chen, F. (2015). Novel optical coherence tomography classification of torpedo maculopathy. Clinical and Experimental Ophthalmology, 43(4), 342-348. [More Information]
• Au, C., Fardell, N., Williams, M., Fraser-Bell, S., Campain, A., Gillies, M. (2015). Patient experiences in retinal trials: a cross-sectional study. BMC Ophthalmology, 15(1), 1-7. [More Information]
• Mehta, H., Gillies, M., Fraser-Bell, S. (2015). Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema. Therapeutic Advances in Chronic Diseases, 6(5), 234-245. [More Information]

2014

• Gillies, M., Lim, L., Campain, A., Quin, G., Salem, W., Li, J., Goodwin, S., Aroney, C., McAllister, I., Fraser-Bell, S. (2014). A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema: The BEVORDEX Study. Ophthalmology, 121(12), 2473-2481. [More Information]
• Vaze, A., Fraser-Bell, S., Gillies, M. (2014). Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration. Acta Ophthalmologica, 92(8), e697-e698. [More Information]
• Fraser-Bell, S. (2014). Preventing vision loss from advanced age-related macular degeneration. Clinical and Experimental Ophthalmology, 42(5), 409-410. [More Information]
• Vaze, A., Fraser-Bell, S., Gillies, M. (2014). Reasons for discontinuation of intravitreal vascular endothelial growth factor inhibitors in neovascular age-related macular degeneration. Retina, 34(9), 1774-1778. [More Information]
• Toniolo, J., Hall, A., Sims, J., Fraser-Bell, S., Khan, J., Younan, C., Kent-Smith, B., Young, S., Paul, E., Lim, L. (2014). Retrospective analysis of the natural history and management of serpiginous choroiditis in Australia and New Zealand. Clinical and Experimental Ophthalmology, 42(7), 656-664. [More Information]

2013

• Liew, G., Quin, G., Gillies, M., Fraser-Bell, S. (2013). Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clinical and Experimental Ophthalmology, 41(2), 201-214. [More Information]
• Quin, G., Liew, G., Ho, I., Gillies, M., Fraser-Bell, S. (2013). Diagnosis and interventions for central serous chorioretinopathy: review and update. Clinical and Experimental Ophthalmology, 41(2), 187-200. [More Information]
• Karim, R., Sykakis, E., Lightman, S., Fraser-Bell, S. (2013). Interventions for the treatment of uveitic macular edema: a systematic review and meta analysis. Clinical Ophthalmology, 7, 1109-1144. [More Information]

2012

• Rajendram, R., Fraser-Bell, S., Kaines, A., Michaelides, M., Hamilton, R., Degli Esposti, S., Peto, T., Egan, C., Bunce, C., Leslie, R., et al (2012). A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular Edema: 24-Month Data: Report 3. Archives of Ophthalmology, 130(8), 972-979. [More Information]
• Salem, W., Fraser-Bell, S., Gillies, M. (2012). Clinical development of new treatments for diabetic macular oedema. Clinical and Experimental Optometry, 95(3), 297-305. [More Information]

2011

• Fung, A., Azar, D., Fraser-Bell, S., McCluskey, P., Grigg, J. (2011). Ockham's razor revisited: Decreased visual acuity secondary to keratoconus in a patient with intracranial hypertension. BMJ Case Reports, 2011 (17 February 2011). [More Information]
• Atan, D., Fraser-Bell, S., Plskova, J., Kuffova, L., Hogan, A., Tufail, A., Kilmartin, D., Forrester, J., Bidwell, J., Dick, A., et al (2011). Punctate inner choroidopathy and multifocal choroiditis with panuveitis share haplotypic associations with IL10 and TNF loci. Investigative Ophthalmology and Visual Science, 52(6), 3573-3581. [More Information]
• Fraser-Bell, S., Gillies, M. (2011). Retinal conditions - Part 1. Australian Doctor, 22, 27-32.
• Fraser-Bell, S., Gillies, M. (2011). Retinal conditions - Part 2. Australian Doctor, 29, 25-32.

2010

• Michaelides, M., Kaines, A., Hamilton, R., Fraser-Bell, S., Rajendram, R., Quhill, F., Boos, C., Xing, W., Egan, C., Peto, T., et al (2010). A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology, 117(6), 1078-1086. [More Information]
• Atan, D., Fraser-Bell, S., Plskova, J., Kuffova, L., Hogan, A., Tufail, A., Kilmartin, D., Forrester, J., Bidwell, J., Dick, A., et al (2010). Cytokine polymorphism in noninfectious uveitis. Investigative Ophthalmology and Visual Science, 51(8), 4133-4142. [More Information]
• Michaelides, M., Fraser-Bell, S., Hamilton, R., Kaines, A., Egan, C., Bunce, C., Peto, T. (2010). Macular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (Bolt Study): Report 1. Retina, 30(5), 781-786. [More Information]
• Fraser-Bell, S., Choudhury, F., Klein, R., Azen, S., Varma, R. (2010). Ocular Risk Factors for Age-Related Macular Degeneration: The Los Angeles Latino Eye Study. American Journal of Ophthalmology, 149(5), 735-740. [More Information]
• Essex, R., Wong, J., Fraser-Bell, S., Sandbach, J., Tufail, A., Bird, A., Dowler, J. (2010). Punctate inner choroidopathy: Clinical Features and outcomes. Archives of Ophthalmology, 128(8), 982-987. [More Information]

2009

• Hooper, C., Lamoureux, E., Lim, L., Fraser-Bell, S., Yeoh, J., Harper, C., Keeffe, J., Guymer, R. (2009). Cataract surgery in high-risk age-related macular degeneration: A randomized controlled trial. Clinical and Experimental Ophthalmology, 37(6), 570-576. [More Information]

2008

• Fraser-Bell, S., Pavesio, C. (2008). Advances in the treatment of intermediate and posterior uveitis. Expert Review of Ophthalmology, 3(4), 449-456. [More Information]
• Fraser-Bell, S., Wu, J., Klein, R., Azen, S., Hooper, C., Foong, A., Varma, R. (2008). Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study. American Journal of Ophthalmology, 145(2), 308-316. [More Information]
• Fraser-Bell, S., Kaines, A., Hykin, P. (2008). Update on treatments for diabetic macular edema. Current Opinion in Ophthalmology, 19(3), 185-189. [More Information]

2007

• Fung, A., Fraser-Bell, S., Ojaimi, E., Sutton, G. (2007). In vivo confocal microscopy and polarizing microscopy of the cornea in a patient with nephropathic cystinosis. Clinical and Experimental Ophthalmology, 35, 292-293. [More Information]

2006

• Hooper, C., Fraser-Bell, S., Farinelli, A., Grigg, J. (2006). Complicated hyphaema: think sickle. Clinical and Experimental Ophthalmology, 34(4), 377-378. [More Information]
• Fraser-Bell, S., Wu, J., Klein, R., Azen, S., Varma, R., Latino Eye Study Group, L. (2006). Smoking, Alcohol Intake, Estrogen Use, and Age-related Macular Degeneration in Latinos: the Los Angeles Latino Eye Study. American Journal of Ophthalmology, 141(1), 79-87. [More Information]

2005

• De Moura, C., Fraser-Bell, S., Stout, A., Labree, L., Nilfors, M., Varma, R. (2005). Experience with the Baerveldt glaucoma implant in the management of pediatric glaucoma. American Journal of Ophthalmology, 139(5), 847-854. [More Information]
• Shufelt, C., Fraser-Bell, S., Ying-Lai, M., Torres, M., Varma, R., Los Angeles Latino Eye Study Group, -. (2005). Refractive error, ocular biometry, and lens opalescence in an adult population: The Los Angeles Latino Eye Study. Investigative Ophthalmology and Visual Science, 46(12), 4450-4460. [More Information]
• Fraser-Bell, S., Donofrio, J., Wu, J., Klein, R., Azen, S., Varma, R., Los Angeles Latino Eye Study Group, -. (2005). Sociodemographic factors and age-related macular degeneration in Latinos: The Los Angeles Latino Eye Study. American Journal of Ophthalmology, 139(1), 30-38. [More Information]

2004

• Fraser-Bell, S., Ying-Lai, M., Klein, R., Varma, R., Los Angeles Latino Eye Study Group, -. (2004). Prevalence and Associations of Epiretinal Membranes in Latinos: The Los Angeles Latino Eye Study. Investigative Ophthalmology and Visual Science, 45(6), 1732-1736. [More Information]
• Varma, R., Fraser-Bell, S., Tan, S., Klein, R., Azen, S., Los Angeles Latino Eye Study Group, -. (2004). Prevalence of age-related macular degeneration in Latinos: The Los Angeles Latino eye study. Ophthalmology, 111(7), 1288-1297. [More Information]

2003

• Guzowski, M., Fraser-Bell, S., Rochtchina, E., Wang, J., Mitchell, P. (2003). Asymmetric refraction in an older population: the Blue Mountains Eye Study. American Journal of Ophthalmology, 136(3), 551-553. [More Information]
• Fraser-Bell, S., Varma, R. (2003). Eye Disease in Latinos. International Ophthalmology Clinics, 43(4), 79-89. [More Information]
• Fraser-Bell, S., Guzowski, M., Rochtchina, E., Wang, J., Mitchell, P. (2003). Five-year cumulative incidence and progression of epiretinal membranes. Ophthalmology, 110(1), 34-40. [More Information]